Glenmark Pharma gets tentative nod from USFDA for cancer treatment drug

Glenmark Pharmaceuticals Inc, USA has received tentative approval by the United States Food & Drug Administration (USFDA) for Axitinib tablets in the strength of 1 mg and 5 mg, the company said in a regulatory filing.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/2Jf6qfy
via IFTTT